{
  "variants": [
    {
      "gene": "ND5",
      "variant": "m.12397A>G (p.T21A)",
      "functional_evidence": [
        {
          "assay_type": "Superoxide production measurement",
          "result": "Enhanced superoxide production in patient fibroblasts, abrogated by complex I inhibitors.",
          "controls": "Not explicitly stated, but complex I inhibitors used as functional validation.",
          "replicates": "Not explicitly mentioned.",
          "acmg_step": "3a",
          "judgment": "Insufficient controls/replicates; proceed to 3b."
        },
        {
          "assay_type": "Enzyme kinetics (NADH:ubiquinone oxidoreductase)",
          "result": "Altered substrate affinity observed in patient fibroblasts.",
          "controls": "Not explicitly stated.",
          "replicates": "Not explicitly mentioned.",
          "acmg_step": "3b",
          "judgment": "Assay is a standard technique for complex I function; functional evidence strength is Max PS3_supporting / Max BS3_supporting."
        }
      ],
      "acmg_strength": "PS3_supporting",
      "rationale": "The variant is associated with a clear functional defect in complex I activity (superoxide production and enzyme kinetics), but lacks explicit controls/replicates. The assay is historically accepted, leading to PS3_supporting classification."
    },
    {
      "gene": "ND6",
      "variant": "m.14319T>C (p.N119D)",
      "functional_evidence": [
        {
          "assay_type": "Superoxide production measurement",
          "result": "Enhanced superoxide production in patient fibroblasts, abrogated by complex I inhibitors.",
          "controls": "Not explicitly stated, but complex I inhibitors used as functional validation.",
          "replicates": "Not explicitly mentioned.",
          "acmg_step": "3a",
          "judgment": "Insufficient controls/replicates; proceed to 3b."
        },
        {
          "assay_type": "Enzyme kinetics (NADH:ubiquinone oxidoreductase)",
          "result": "Altered substrate affinity observed in patient fibroblasts.",
          "controls": "Not explicitly stated.",
          "replicates": "Not explicitly mentioned.",
          "acmg_step": "3b",
          "judgment": "Assay is a standard technique for complex I function; functional evidence strength is Max PS3_supporting / Max BS3_supporting."
        }
      ],
      "acmg_strength": "PS3_supporting",
      "rationale": "The variant is associated with a clear functional defect in complex I activity (superoxide production and enzyme kinetics), but lacks explicit controls/replicates. The assay is historically accepted, leading to PS3_supporting classification."
    }
  ]
}